Epidemiology of clinical feline herpesvirus infection in zoo-housed cheetahs (Acinonyx jubatus)

POSTVACCINAL VIRAL DISEASE PRESENTATION IN TWO LITTERS OF CHEETAHS (ACINONYX JUBATUS)

Protective antibody titers against core vaccines have not been standardized for cheetahs (Acinonyx jubatus) under human care. Vaccine-induced disease has been suspected after administration of modified live virus vaccine (MLVV), but it has not been confirmed as the causative agent. MLVV and killed virus vaccines (KVV) elicit humoral response in cheetahs; however, the use of both vaccines for initial immunization in cheetah cubs <6 months old within the same population has not been reported. The current case series describes viral disease presentation in two cheetah litters after using both vaccines and presents results for serum neutralization titers against feline calicivirus (FCV) and feline herpesvirus-1 (FHV-1) and hemagglutination inhibition titers against feline panleukopenia virus (FPV). For Litter 1, MLVV was administered at 6 and 9 wk old. On week 11, one male developed ocular, oral, and dermal lesions. Viral isolation recovered FCV. Because of suspected vaccine-induced FCV, KVV was administered on weeks 13 and 16. Litter 2 was vaccinated with KVV via the same vaccination schedule. Fifty-three days after the last booster, two cubs presented with ocular, respiratory, and oral clinical signs; both were PCR positive for FHV-1. Serology reported a better anamnestic response and protective titers against FCV and FPV with the protocol used with Litter 1. In Litter 2, FCV and FHV-1 titer measurement failed in three of four cubs, limiting comparison of titers between litters. In spite of limited measurements, absence of a statistical evaluation, and presence of infection, serology showed a better humoral response when MLVV was used.

Full Viral Genome Sequencing and Phylogenomic Analysis of Feline Herpesvirus Type 1 (FHV-1) in Cheetahs (Acinonyx jubatus)

Feline herpesvirus type 1 (FHV-1) is endemic in captive cheetahs and sporadically causes devastating disease. Modified live vaccines (MLV), intended for use in domestic cats, are used in some captive cheetah populations and have been anecdotally linked to disease in certain subpopulations. Ten FHV-1 isolates from ten captive cheetahs and one isolate from an MLV used to inoculate four of the host animals were analyzed. Viral DNA was extracted for full-genome sequencing by Illumina MiSeq with viral genomes then used for phylogenomic and recombinational analyses. The FHV-1 shed by vaccinated cheetahs were almost identical to the MLV, with few variants among viral genomes. Eight cheetah FHV-1 isolates and the MLV were grouped in a clade along with FHV-1 isolates from domestic cats in the USA. The remaining two cheetah FHV-1 isolates (unknown host vaccine status) were not associated with a clade. The likely ancestral origin of these two isolates involves recombination events between Australian domestic cat and cheetah FHV-1 isolates. Collectively, these data suggest that the MLV is capable of causing clinical disease and viral shedding in some cheetahs and represents evidence of interspecies transmission of virus between domestic and wild cats.

The Patterns and Causes of Dermatitis in Terrestrial and Semi-Aquatic Mammalian Wildlife

Causative disease and stress agents which manifest as dermatitis in mammals have varying effects on individual animals, from benign irritation and inflammation, to causing morbidity and even mortality. Bacteria, viruses and ectoparasites are all potential causes of dermatitis, and it can be exacerbated by various environmental, genetic and social factors. Furthermore, it is uncertain whether dermatitis is more likely to manifest in already-vulnerable wildlife species. Here, we systematically review the literature for reports of dermatitis in terrestrial and semi-aquatic wild mammalian species, with the goal of determining the biogeographical scale of dermatitis reports, the causes of dermatitis, and whether manifestation of dermatitis is reported more commonly in certain wildlife species or their captivity status (i.e., free-living, in captivity or in a laboratory). We reveal biases in the reporting of dermatitis by a biogeographic realm, with 55% of cases reported in the Nearctic, and towards particular orders of mammals, namely Artiodactyla and Carnivora. Overall, free-living wildlife is almost twice as likely to be reported as having dermatitis than individuals in captivity and six times more likely than individuals in laboratories, which we interpret as owing to exposure to a broader spectrum of parasites in free-ranging individuals, and potential reporting bias in captive individuals. Notably, dermatitis was reported in 23 threatened species, with some species more likely than others to be reported exhibiting clinical signs of dermatitis resulting from underlying health problems. We also find that threatened species are more likely to be reported as having dermatitis in captivity, particularly outside of their endemic home range. This review highlights diverse patterns of dermatological disease causes in captive and free-ranging wildlife, conditions under which they are more likely to be documented, and the need for cross-disciplinary research to ascertain (and so better manage) the varied causes.

FELINE HERPESVIRUS INFECTION IN FOUR CAPTIVE CHEETAHS (ACINONYX JUBATUS) POSTVACCINATION

Cheetahs (Acinonyx jubatus) are particularly susceptible to feline herpesvirus-1 (FHV-1). Recommendations for preventive health care in cheetahs include vaccination against FHV-1 using killed and modified live virus (MLV) vaccines. Although MLV vaccines tend to induce a more robust immune response than killed vaccines, they can induce disease. This case series details an FHV-1 outbreak in four adult cheetahs following the use of MLV vaccine in one of them. All four cheetahs developed severe FHV-1 clinical signs and were euthanized. Clinical signs included depression, anorexia, nasal discharge, ocular discharge, sneezing, and ulcerative dermatitis. Herpesvirus infection was diagnosed using history, clinical signs, polymerase chain reaction, and histologic evaluation. The timeline of events suggests the MLV vaccine was the inciting cause, although this was not conclusively proven. Outcome of this case suggests that when considering MLV vaccines for cheetahs, careful risk and benefit discussions are merited.